New US lab for Cyprotex

Macclesfield-based Cyprotex, which provides outsourced services to pharmaceutical companies, has expanded in the US.
The company, a specialist in ADME (absorption, distribution, metabolism, and excretion) testing has launched a new high throughput screening laboratory at its facility in Watertown near Boston.
The new lab replicates the highly successful ADME screening lab in Cheshire which has been developed in-house over the past 16 years.
Dr Anthony Baxter, Cyprotex’s chief executive said: “Expansion of our high throughput screening facility to the US has always been a much desired part of our growth strategy plans. Our unique software platform combined with state of the art automation and bioanalytical capabilities make us one of the only contract research facilities to be able to screen such large numbers of compounds in such a wide range of assays with relative ease. 
“The medium and large pharmaceutical companies who require high capacity and high quality screening with short turnaround times are realising the benefit of working with Cyprotex and as such the number of strategic deals are increasing and are a key factor in the growth of our business.”